🇺🇸 FDA
Patent

US 8822681

Azaindoles useful as inhibitors of janus kinases

granted A61KA61K31/506A61K31/517

Quick answer

US patent 8822681 (Azaindoles useful as inhibitors of janus kinases) held by Vertex Pharmaceuticals Incorporated expires Mon Aug 28 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Vertex Pharmaceuticals Incorporated
Grant date
Tue Sep 02 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 28 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
53
CPC classes
A61K, A61K31/506, A61K31/517, A61K31/53, A61K31/5377